Back to Alzheimers Disease

NCT05997784

NCT05997784
Active, Not Recruiting Not Applicable

Who may be able to join

Who might be able to join this trial:

  • The child must be starting the school year at the CM1 grade level (roughly age 9-10 in the French school system)
  • The child must be in a classroom that has been chosen to take part in this project
  • Both the child and their parent(s) or caregiver(s) must be willing to follow the study's steps and procedures

Who may not be able to join:

  • The child or their parent(s)/guardian(s) do not wish to take part or are not willing to give their consent to join
  • The child or their parent(s)/guardian(s) do not want to use the app provided to fill in questionnaires or follow the study steps
  • The child or their parent(s)/guardian(s) are not able to read and/or write in French
  • The family is planning a long trip away from the local area that would prevent them from attending the scheduled study visits

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Active, Not Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Montpellier
Registry
clinicaltrials_gov
Start date
30 January 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Indoor classroom air concentrations of Pollutants and dust; Prevalence for respiratory disease; Association between asthma and indoor air contaminants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov